Product Code: MCP-7970
This report analyzes the worldwide markets for Deep Brain Stimulation Devices in US$ Thousand. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2014 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as -
Aleva Neurotherapeutics SA
Boston Scientific Corp.
Deep Brain Innovations, LLC
Medtronic, plc
St. Jude Medical, Inc.
Table of Contents
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
- Study Reliability and Reporting Limitations
- Disclaimers
- Data Interpretation & Reporting Level
- Quantitative Techniques & Analytics
- Product Definitions and Scope of Study
- DBS Devices
- Implantable Pulse Generator (IPG)
- The Extension
- Leads/Electrodes
- Other Devices
II. EXECUTIVE SUMMARY
1. INDUSTRY OVERVIEW
- A Foreword
- Introduction to Deep Brain Stimulation Procedure & Devices
- Deep Brain Stimulation - Then and Now
- Sizing the Market for DBS Devices
- Recent Innovations and the Way Ahead
2. MARKET DYNAMICS
- Burgeoning Global Population Offers Significant Growth Opportunities
- Table 1: Top 25 Countries Worldwide in Terms of Population (2010 & 2013) (includes corresponding Graph/Chart)
- Aging Population and Rising Disease Prevalence: The Cornerstone for DBS
- Table 2: Global Population Statistics for 65+ Age Group (2014) (includes corresponding Graph/Chart)
- Table 3: Elderly Population (65+ Years) Worldwide by Geographic Region on the Basis of Economic Status (2000 & 2025): % of Total Population for More Developed Countries, Less Developed Countries and Least Developed Countries (includes corresponding Graph/Chart)
- Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
- Table 4: Healthcare Spending as % of GDP in Select Countries (2013) (includes corresponding Graph/Chart)
- Novel Applications Bode Tremendous Prospects
- Technical Advancements Aid in Progress of DBS
- Questions Arise on the Current Pace of Innovation
- Closed-Loop Functionality Gaining Favor over Open Loop in Neurostimulation
- Investigational DBS Device Inches towards Closed-Loop Functionality
- Closed-Loop Stimulation - A Potential Solution for Gait Disturbances in DBS Treated PD Patients
- Steering Brain Stimulation - An Emerging Concept in DBS
- Novel Investigational Leads Target Selective and Fractional Stimulation
- Novel Electrode Configurations Aid in Localization and Side Effect Reduction
- Nanotechnology - The Future of DBS Electrodes
- On-Demand Stimulators Promise to Contribute to Superior Therapeutic Outcomes
- Advances in Programming Promise Ease of Treatment
- Visual Depiction of Electrical Field Comes to the Aid of Programming
- Device Programmability Gains Precedence in Device Choice
- Brain Imaging - Gaining Prominence in DBS
- Novel Imaging Techniques Come to the Fore
- New DBS Technique Promises Superior Outcomes
- Lack of Large Scale Study Results Subdue Asleep DBS; for Now
- Concerns Remain Afloat - Affecting Adoption
- Hardware-related Infections - A Major Concern
- Battery Life - A Bone of Contention for DBS
3. TARGETED INDICATIONS FOR DBS
- Parkinson's Disease - The Largest Application Market for DBS
- A Note on Incidence and Prevalence of Parkinson's Disease
- Table 5: Global Prevalence of Parkinson's Disease (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart)
- Research Suggests Greater Benefits of DBS in Parkinson's
- DBS - A Highly Effective Therapy for Essential Tremor
- Incidence and Prevalence of Essential Tremor
- DBS in Dystonia
- Clinical Evidence of DBS in Dystonia: An Overview of Results from Select Clinical Studies and Meta-Analyses
- Dystonia Patient Selection Criteria for DBS
- DBS in OCD
- DBS in Epilepsy Treatment
- Table 6: Global Prevalence of Epilepsy (2014): Number of Patients Affected in Thousands for Select Countries/Regions (includes corresponding Graph/Chart)
- DBS in Tourette Syndrome - Research Progress So Far
- Clinical Evidence of DBS in Tourette Syndrome: An Overview of Results from Select Clinical Studies and Meta-Analyses
- Paucity of Effective Drugs Drives Shift in Psychiatric Disorder Treatment
- Multiple Possible Targets Marr Progress of DBS in Depression Treatment
- Overview of Select Studies on DBS in Depression Treatment
- SCC - A Promising Target for Stimulation in Depression
- Eating Disorders - A Note on Potential of DBS
- DBS in Obesity - Animal Models Show Promise
- Anorexia Treatment - Where Does DBS Stand?
- DBS in Dementia Treatment - Animal Studies Bode Well for Efficacy in Humans
- Prospects of DBS in Chronic Pain Management
4. COMPETITIVE LANDSCAPE
- Leading Players
- A Comparison of DBS Devices on the Market
- Timeline for Approvals of Major DBS Systems by Indication in US and EU
- Player Strategies to Market - An Overview
- Timeline for Medtronic DBS Therapy
5. PRODUCT OVERVIEW
- Deep Brain Stimulation - An Overview
- A Brief Note on Birth and Evolution of DBS
- Devices in Deep Brain Stimulation
- Components of DBS System
- Implantable Pulse Generator (IPG)
- The Extension
- Leads/Electrodes
- Other Products used in DBS Procedures
- DBS Procedure - A Brief Overview
- DBS Placement and Calibration
- Common Lead Targets for Select Neurological and Psychiatric Conditions in DBS
- A Peek into Indications of DBS and Other Uses
- DBS Complications
- A Gist of Common Complications Associated with DBS
6. PRODUCT APPROVALS/INTRODUCTIONS
- Medtronic Obtains EU Clearance for Full-Body MR Conditional DBS Systems
- Boston Scientific Obtains CE Mark for Vercise™ DBS System for Treating Tremor
- Boston Scientific Obtains CE Mark for Vercise™ DBS System for Dystonia Treatment
- St. Jude Medical Obtains CE Mark Approval for its DBS Systems in Dystonia Treatment
- EBS Technologies Secures CE Mark Approval for Next Wave DBS System
- Boston Scientific Secures CE Mark Approval for GUIDE™ DBS Visualization System
- Boston Scientific Obtains CE Mark for Vercise™ DBS System for Parkinson's Disease
7. RECENT INDUSTRY ACTIVITY
- Boston Scientific and Brainlab Team Up for DBS Therapy
- Medtronic to Refile for FDA Approval for its DBS System in Epilepsy Treatment
- Medtronic Publishes Positive Results from SANTE Trial Evaluating DBS in Epilepsy
- Kelyniam Takes Over MED-ALLY
- Medtronic Acquires Sapiens SBS
- Boston Scientific Publishes Interim Results from VANTAGE Trial Evaluating Vercise DBS System for Parkinson's Disease
- Boston Scientific Publishes Positive Results from CUSTOM DBS Clinical Study on Vercise™ DBS System
- Aleva Publishes Positive Results from Intraoperative Study using directSTIM™ Directional Lead
- Boston Scientific Commences New Clinical Trial for its DBS System in Parkinson's Disease Treatment
- Medtronic Announces First Research Implant of Activa® PC+S DBS System in US
- Functional Neuromodulation Obtains FDA Clearance to Expand DBS Study for Alzheimer's
- Venture Firm NDI Medical Commences New Portfolio Company Deep Brain Innovations, LLC
8. FOCUS ON SELECT PLAYERS
- Aleva Neurotherapeutics SA (Switzerland)
- Boston Scientific Corp. (US)
- Deep Brain Innovations, LLC (US)
- Medtronic, plc (US)
- St. Jude Medical, Inc. (US)
9. GLOBAL MARKET PERSPECTIVE
- Table 7: World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 8: World Historic Review for Deep Brain Stimulation Devices by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
- Table 9: World 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
III. MARKET
1. THE UNITED STATES
- A. Market Analysis
- Current & Future Analysis
- Aging Population and Rising Prevalence of Neurological Disorders: A Strong Market Driver
- Table 10: US Population Breakdown by Age Group (2014) (includes corresponding Graph/Chart)
- Table 11: Prevalence of Major Neurological Disorders in the US (includes corresponding Graph/Chart)
- Table 12: North American Elderly Population in Thousands by Age Group (1975-2050) (includes corresponding Graph/Chart)
- Increasing Research Funding to Help DBS
- DBS Reimbursement Scenario in the US
- Medicare ICD-9-CM Diagnosis Codes for DBS
- Medicare ICD 9 CM Diagnosis Procedure Codes for DBS
- Medicare HCPCS II Device Codes for DBS
- CPT® Procedure Codes and Facility Payment for DBS for the period January to March 2015
- CPT® Procedure Codes and Hospital Outpatient Payment for the period January to December 2015
- CPT® Procedure Codes and Hospital Inpatient Payment for the Period October 2014 to September 2015
- CPT® Procedure Codes and Ambulatory Surgical Center (ASC) Payment for the period January to December 2015
- Strategic Corporate Developments
- Select Key Players
- B. Market Analytics
- Table 13: US Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 14: US Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
2. CANADA
- A. Market Analysis
- B. Market Analytics
- Table 15: Canadian Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 16: Canadian Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
3. JAPAN
- A. Market Analysis
- Current & Future Analysis
- Graying Population Spurs Growth of CNS Therapeutics
- Table 17: Japanese Elderly (65+ Years) Population: 2000-2020 (includes corresponding Graph/Chart)
- DBS Approvals in Japan
- List of Approved and Investigational Indications for Deep Brain Stimulation
- B. Market Analytics
- Table 18: Japanese Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 19: Japanese Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
4. EUROPE
- A. Market Analysis
- Current & Future Analysis
- Ageing Population Boost DBS Devices Demand
- Table 20: European Country-wise Statistics of 60+ Population as % of Total Population: 2013 (includes corresponding Graph/Chart)
- A Brief Note on German DBS Devices Market
- Product Approvals/Launches
- Strategic Corporate Developments
- Aleva Neurotherapeutics SA - A Switzerland- based DBS Device Developer
- B. Market Analytics
- Table 21: European Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 22: European Historic Review for Deep Brain Stimulation Devices by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
- Table 23: European 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5. ASIA-PACIFIC
- A. Market Analysis
- Current & Future Analysis
- India & China Offer Significant Growth Opportunities
- Table 24: China and India Lead Global Population (2014): Table Depicting China and India's Huge Population Vis-a-vis Other Countries' Population (in Thousands) by Age Group (includes corresponding Graph/Chart)
- B. Market Analytics
- Table 25: Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 26: Asia-Pacific Historic Review for Deep Brain Stimulation Devices by Geographic Region - China, India and Rest of Asia-Pacific Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
- Table 27: Asia-Pacific 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for China, India and Rest of Asia-Pacific Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
5a. CHINA
- A. Market Analysis
- Current & Future Analysis
- Market Overview
- Breaking the Monopoly of Global Giants
- B. Market Analytics
- Table 28: Chinese Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 29: Chinese Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
5b. INDIA
- A. Market Analysis
- Current & Future Analysis
- Indian DBS Market on the Roll
- Growing Medical Tourism to Support DBS Market in India
- B. Market Analytics
- Table 30: Indian Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 31: Indian Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
5c. REST OF ASIA-PACIFIC
- A. Market Analysis
- Current & Future Analysis
- Overview of the Australian DBS Market
- B. Market Analytics
- Table 32: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 33: Rest of Asia-Pacific Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
6. LATIN AMERICA
- Market Analysis
- Table 34: Latin American Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 35: Latin American Historic Review for Deep Brain Stimulation Devices by Geographic Region - Brazil and Rest of Latin American Markets Independently Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
- Table 36: Latin American 14-Year Perspective for Deep Brain Stimulation Devices by Geographic Region - Percentage Breakdown of Value Sales for Brazil and Rest of Latin American Markets for Years 2007, 2015 & 2020 (includes corresponding Graph/Chart)
7. REST OF WORLD
- Market Analysis
- Table 37: Rest of World Recent Past, Current & Future Analysis for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2014 through 2020 (includes corresponding Graph/Chart)
- Table 38: Rest of World Historic Review for Deep Brain Stimulation Devices Market - Analyzed with Annual Sales Figures in US$ Thousand for Years 2007 through 2013 (includes corresponding Graph/Chart)
COMPETITIVE LANDSCAPE
